<SEC-DOCUMENT>0001950047-24-005419-index.html : 20240715
<SEC-HEADER>0001950047-24-005419.hdr.sgml : 20240715
<ACCEPTANCE-DATETIME>20240715163105
ACCESSION NUMBER:		0001950047-24-005419
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240715
DATE AS OF CHANGE:		20240715

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kymera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001815442
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				812992166
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39460
		FILM NUMBER:		241117639

	BUSINESS ADDRESS:	
		STREET 1:		500 NORTH BEACON STREET, 4TH FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		857-285-5314

	MAIL ADDRESS:	
		STREET 1:		500 NORTH BEACON STREET, 4TH FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gollob Jared
		CENTRAL INDEX KEY:			0001821198
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O KYMERA THERAPEUTICS, INC.
		STREET 2:		200 ARSENAL YARDS, SUITE 230
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>